These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23732354)

  • 21. Home oxygen therapy after hospital discharge.
    Pirr S; Peter C
    Semin Fetal Neonatal Med; 2020 Apr; 25(2):101082. PubMed ID: 32014368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a short course of prednisolone in infants with oxygen-dependent bronchopulmonary dysplasia.
    Bhandari A; Schramm CM; Kimble C; Pappagallo M; Hussain N
    Pediatrics; 2008 Feb; 121(2):e344-9. PubMed ID: 18245407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Room air challenge: prediction for successful weaning of oxygen-dependent infants.
    Simoes EA; Rosenberg AA; King SJ; Groothuis JR
    J Perinatol; 1997; 17(2):125-9. PubMed ID: 9134511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of pulmonary follow-up in reducing health care utilization in infants with bronchopulmonary dysplasia.
    Rhein LM; Konnikova L; McGeachey A; Pruchniewski M; Smith VC
    Clin Pediatr (Phila); 2012 Jul; 51(7):645-50. PubMed ID: 22492835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex differences after NICU discharge in infants with BPD: Observations from one center.
    O'Connor MG; Moore PE
    Pediatr Pulmonol; 2017 Jan; 52(1):7-9. PubMed ID: 27640903
    [No Abstract]   [Full Text] [Related]  

  • 26. Home oxygen delivery system for infants.
    Zinman R; Franco I; Pizzuti-Daechsel R
    Pediatr Pulmonol; 1985; 1(6):325-7. PubMed ID: 4094824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic hypertension in infants with severe bronchopulmonary dysplasia: associated clinical factors.
    Anderson AH; Warady BA; Daily DK; Johnson JA; Thomas MK
    Am J Perinatol; 1993 May; 10(3):190-3. PubMed ID: 8517893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variability in duration of outpatient diuretic therapy in bronchopulmonary dysplasia: a clinical experience.
    Bhandari A; Chow U; Hagadorn JI
    Am J Perinatol; 2010 Aug; 27(7):529-35. PubMed ID: 20178069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Home oxygen treatment of an infant with bronchopulmonary dysplasia].
    Astrup G
    Ugeskr Laeger; 1988 May; 150(20):1235-6. PubMed ID: 3376305
    [No Abstract]   [Full Text] [Related]  

  • 30. The changing face of bronchopulmonary dysplasia: Part 2. Discharging an infant home on oxygen.
    Gracey K; Talbot D; Lankford R; Dodge P
    Adv Neonatal Care; 2003 Apr; 3(2):88-98. PubMed ID: 12881950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The management of bronchopulmonary dysplasia.
    Monin P; Vert P
    Clin Perinatol; 1987 Sep; 14(3):531-49. PubMed ID: 3311538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The neonatal ICU graduate: Part I. Common problems.
    Hulseman ML; Norman LA
    Am Fam Physician; 1992 Mar; 45(3):1301-5. PubMed ID: 1543111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of infants with bronchopulmonary dysplasia in Germany.
    Thomas W; Speer CP
    Early Hum Dev; 2005 Feb; 81(2):155-63. PubMed ID: 15748970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic interventions and short-term outcomes for infants with severe bronchopulmonary dysplasia born at <32 weeks' gestation.
    Padula MA; Grover TR; Brozanski B; Zaniletti I; Nelin LD; Asselin JM; Durand DJ; Short BL; Pallotto EK; Dykes FD; Reber KM; Evans JR; Murthy K
    J Perinatol; 2013 Nov; 33(11):877-81. PubMed ID: 23828204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension.
    Brownlee JR; Beekman RH; Rosenthal A
    Pediatr Res; 1988 Aug; 24(2):186-90. PubMed ID: 3186330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there a strategy for preventing bronchopulmonary dysplasia? Absence of evidence is not evidence of absence.
    Aly H
    Pediatrics; 2007 Apr; 119(4):818-20. PubMed ID: 17403854
    [No Abstract]   [Full Text] [Related]  

  • 37. Beyond the NICU: Comprehensive management of infants with bronchopulmonary dysplasia in the PICU.
    Stickney CA; Levy PT; Abecassis L; Levin JC
    Pediatr Pulmonol; 2023 May; 58(5):1602-1606. PubMed ID: 36840405
    [No Abstract]   [Full Text] [Related]  

  • 38. Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia.
    Abman SH; Wolfe RR; Accurso FJ; Koops BL; Bowman CM; Wiggins JW
    Pediatrics; 1985 Jan; 75(1):80-4. PubMed ID: 3838113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence-based methylxanthine use in the NICU.
    Spitzer AR
    Clin Perinatol; 2012 Mar; 39(1):137-48. PubMed ID: 22341542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxaemia in infants with bronchopulmonary dysplasia.
    Poets CF; Samuels MP; Southall DP
    Pediatrics; 1993 Jul; 92(1):186-7. PubMed ID: 8516075
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.